AT342583B - Verfahren zur herstellung von neuen carbazol-derivaten - Google Patents

Verfahren zur herstellung von neuen carbazol-derivaten

Info

Publication number
AT342583B
AT342583B AT596074A AT596074A AT342583B AT 342583 B AT342583 B AT 342583B AT 596074 A AT596074 A AT 596074A AT 596074 A AT596074 A AT 596074A AT 342583 B AT342583 B AT 342583B
Authority
AT
Austria
Prior art keywords
carbazole derivatives
producing new
new carbazole
producing
derivatives
Prior art date
Application number
AT596074A
Other languages
German (de)
English (en)
Other versions
ATA596074A (de
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2337154A external-priority patent/DE2337154C2/de
Priority claimed from DE2431292A external-priority patent/DE2431292A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of ATA596074A publication Critical patent/ATA596074A/de
Application granted granted Critical
Publication of AT342583B publication Critical patent/AT342583B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT596074A 1973-07-18 1974-07-18 Verfahren zur herstellung von neuen carbazol-derivaten AT342583B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2337154A DE2337154C2 (de) 1973-07-18 1973-07-18 Neue Carbazolderivate
DE2431292A DE2431292A1 (de) 1974-06-27 1974-06-27 Neue carbazol-derivate

Publications (2)

Publication Number Publication Date
ATA596074A ATA596074A (de) 1977-08-15
AT342583B true AT342583B (de) 1978-04-10

Family

ID=25765532

Family Applications (1)

Application Number Title Priority Date Filing Date
AT596074A AT342583B (de) 1973-07-18 1974-07-18 Verfahren zur herstellung von neuen carbazol-derivaten

Country Status (20)

Country Link
JP (1) JPS5069072A (xx)
AT (1) AT342583B (xx)
BG (1) BG25793A3 (xx)
CA (1) CA1053682A (xx)
CH (1) CH619213A5 (xx)
CS (1) CS190431B2 (xx)
DD (1) DD114075A5 (xx)
DK (1) DK388074A (xx)
ES (1) ES428379A1 (xx)
FI (1) FI218874A (xx)
FR (1) FR2237628B1 (xx)
GB (1) GB1482771A (xx)
HU (1) HU173115B (xx)
IE (1) IE39624B1 (xx)
IL (1) IL45298A (xx)
NL (1) NL7409715A (xx)
NO (1) NO742601L (xx)
RO (1) RO72713A (xx)
SE (1) SE396602B (xx)
SU (1) SU511855A3 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4908215B2 (ja) * 2003-09-12 2012-04-04 エリクサー ファーマスーティカルズ インコーポレイテッド 疾患の治療法
US20060074124A1 (en) * 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
EP1817025A2 (en) 2004-11-23 2007-08-15 PTC Therapeutics, Inc. Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
AR088377A1 (es) * 2011-10-20 2014-05-28 Siena Biotech Spa Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta
CA3059631A1 (en) * 2017-04-11 2018-10-18 Saje Pharma, Llc Carbazole compounds and methods of use thereof
JP2021134141A (ja) * 2020-02-21 2021-09-13 エヌ・イーケムキャット株式会社 不均一系貴金属触媒を用いた芳香族化合物の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7008628A (xx) * 1969-06-25 1970-12-29

Also Published As

Publication number Publication date
SU511855A3 (ru) 1976-04-25
NL7409715A (nl) 1975-01-21
ES428379A1 (es) 1976-09-16
BG25793A3 (en) 1978-12-12
CH619213A5 (en) 1980-09-15
FR2237628B1 (xx) 1977-05-20
ATA596074A (de) 1977-08-15
IE39624L (en) 1975-01-18
CS190431B2 (en) 1979-05-31
SE396602B (sv) 1977-09-26
JPS5069072A (xx) 1975-06-09
DD114075A5 (xx) 1975-07-12
HU173115B (hu) 1979-02-28
FR2237628A1 (xx) 1975-02-14
NO742601L (xx) 1975-02-17
IL45298A0 (en) 1974-10-22
DK388074A (xx) 1975-03-03
GB1482771A (en) 1977-08-17
IL45298A (en) 1980-01-31
SE7409330L (xx) 1975-01-20
RO72713A (ro) 1982-09-09
CA1053682A (en) 1979-05-01
FI218874A (xx) 1975-01-19
IE39624B1 (en) 1978-11-22

Similar Documents

Publication Publication Date Title
AT335419B (de) Verfahren zur herstellung von neuen 2-cyclohexen-1-on-derivaten
AT347054B (de) Verfahren zur herstellung von neuen nonapeptidamid-derivaten
AT347053B (de) Verfahren zur herstellung von neuen nonapeptidamid-derivaten
AT326137B (de) Verfahren zur herstellung von neuen 3-phenyl-6-halogen-pyridanzinverbindungen
AT341521B (de) Verfahren zur herstellung von neuen oxazolderivaten
ATA1021774A (de) Verfahren zur herstellung von neuen pregnan-21-saeure-derivaten
AT331399B (de) Verfahren zur herstellung von neuen azetidinderivaten
AT335607B (de) Verfahren zur herstellung von neuen beta-lactamantibiotica
AT339913B (de) Verfahren zur herstellung von neuen diazin-derivaten
AT342583B (de) Verfahren zur herstellung von neuen carbazol-derivaten
AT333952B (de) Verfahren zur herstellung von neuen 3-halogencephalosporinverbindungen
AT339296B (de) Verfahren zur herstellung von neuen xanthenderivaten
AT338240B (de) Verfahren zur herstellung von neuen phenoxyathylaminen
AT339310B (de) Verfahren zur herstellung von neuen chinolinderivaten
AT327407B (de) Verfahren zur herstellung von neuen benzomorphanderivaten
AT330160B (de) Verfahren zur herstellung von neuen biphenyl-derivaten
AT345997B (de) Verfahren zur herstellung von neuen pyrimidinoaminomethylergolinderivaten
ATA874574A (de) Verfahren zur herstellung von neuen 1-phthalazonderivaten
AT336606B (de) Verfahren zur herstellung von neuen tetrazol-5-yl-cumarinderivaten
ATA255374A (de) Verfahren zur herstellung von neuen substituierten formamidinderivaten
AT340406B (de) Verfahren zur herstellung von neuen isoindolderivaten
ATA471176A (de) Verfahren zur herstellung von neuen 1-phthalazonderivaten
AT338259B (de) Verfahren zur herstellung von neuen indolderivaten
AT336812B (de) Verfahren zur herstellung von neuen 21-fluor-19-norpregnadienverbindungen
ATA576675A (de) Verfahren zur herstellung von neuen 21-fluor-19-norpregnadienverbindungen